MedTrace Logo

The SCCS Polypill Pilot Trial

NCT02278471 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2021-05-14

Study results available
· View outcomes & findings →

Summary

In this study the investigators will examine the effect of the polypill on medication adherence, systolic blood pressure, and LDL cholesterol over a 12 month span.

Conditions

Interventions

DRUG

Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Thomas J Wang, MD · Vanderbilt Univeristy

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-06-27
Completion
2018-06-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278471 on ClinicalTrials.gov